Cerebrovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with cerebral apoplexy combined with poststroke cognitive impairment (PSCI) who received treatment in our hospital from January 2022 to May 2024; 2. In accordance with the diagnostic criteria of Chinese Medical Association for acute stroke, the vital signs were basically stable and confirmed by head CT or MRI examination; 3. MRS<=2 before onset, no cognitive impairment; 4. Cognitive impairment was determined this time, and the MOCA score was less than 26, which was able to cooperate with the completion of relevant assessment and detection; 5. 40 years <= age < 80 years; 6. Within 2 weeks of the onset of stroke; 7. Patients or their legal representatives sign informed consent before joining the group.
Exclusion criteria
Exclusion criteria: 1. Severe hearing or speech impairment; 2. Mental abnormalities or epilepsy caused by various reasons or unable to correctly assess cognitive function; 3. Patients with brain and heart pacemakers; 4. Patients with special constitution and allergy to multiple drugs; 5. Patients with definite causes of cognitive impairment, such as syphilis, AIDS, thyroid dysfunction, VitB12 deficiency, Notch3 gene mutation, etc.; 6. Patients with severe functional failure and critical condition of important organs and life expectancy of less than 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of Mini-mental State Examination;The score of Montreal Cognitive Assessment;Formaldehyde concentration in blood; Formaldehyde concentration in urine; | — |
Secondary
| Measure | Time frame |
|---|---|
| The score of Hamilton Depression Scale (HAMD);The score of Hamilton Anxiety Scale (HAMA);The score of National Institute of Health Stroke Scale (NIHSS);The score of Activities of Daily Living (ADL); | — |
Countries
China